Jiayan Li

State Key Laboratory Of Genetics And Development Of Complex Phenotypes, Shanghai Key Laboratory Of Oncology Target Discovery And Antibody Drug Development
Shanghai, 200438, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Evolving SARS-CoV-2 Vaccines: From Current Solutions to Broad-Spectrum Protection.

Evolving SARS-CoV-2 Vaccines: From Current Solutions to Broad-Spectrum Protection.

Journal: Vaccines

Published: April 30, 2025

Orphan broadly RBD-binding antibodies annotate three remaining conserved RBD epitopes along SARS-CoV-2 evolution.

Orphan broadly RBD-binding antibodies annotate three remaining conserved RBD epitopes along SARS-CoV-2 evolution.

Journal: Nature communications

Published: April 14, 2025

Pathogenicity, virological features, and immune evasion of SARS-CoV-2 JN.1-derived variants including JN.1.7, KP.2, KP.3, and KP.3.1.1.

Pathogenicity, virological features, and immune evasion of SARS-CoV-2 JN.1-derived variants including JN.1.7, KP.2, KP.3, and KP.3.1.1.

Journal: Nature communications

Published: April 10, 2025

Vascular endothelial growth factor receptor 2 as a potential host target for the inhibition of enterovirus replication.

Vascular endothelial growth factor receptor 2 as a potential host target for the inhibition of enterovirus replication.

Journal: Journal of virology

Published: September 17, 2024

Potent and broadly neutralizing antibodies against sarbecoviruses elicited by single ancestral SARS-CoV-2 infection.

Potent and broadly neutralizing antibodies against sarbecoviruses elicited by single ancestral SARS-CoV-2 infection.

Journal: Communications biology

Published: July 19, 2024

Novel Trispecific Neutralizing Antibodies With Enhanced Potency and Breadth Against Pan-Sarbecoviruses.

Novel Trispecific Neutralizing Antibodies With Enhanced Potency and Breadth Against Pan-Sarbecoviruses.

Journal: MedComm

Published: May 28, 2024

Broad-spectrum coronavirus neutralization induced by hetero RBD-Fc protein vaccine.

Broad-spectrum coronavirus neutralization induced by hetero RBD-Fc protein vaccine.

Journal: Journal of medical virology

Published: May 08, 2024

Lineage-specific pathogenicity, immune evasion, and virological features of SARS-CoV-2 BA.2.86/JN.1 and EG.5.1/HK.3.

Lineage-specific pathogenicity, immune evasion, and virological features of SARS-CoV-2 BA.2.86/JN.1 and EG.5.1/HK.3.

Journal: Nature communications

Published: April 12, 2024

Longitudinal Analysis of Humoral and Cellular Immune Response up to 6 Months after SARS-CoV-2 BA.5/BF.7/XBB Breakthrough Infection and BA.5/BF.7-XBB Reinfection.

Longitudinal Analysis of Humoral and Cellular Immune Response up to 6 Months after SARS-CoV-2 BA.5/BF.7/XBB Breakthrough Infection and BA.5/BF.7-XBB Reinfection.

Journal: Vaccines

Published: March 25, 2024

Enhanced neutralization of SARS-CoV-2 variant BA.2.86 and XBB sub-lineages by a tetravalent COVID-19 vaccine booster.

Enhanced neutralization of SARS-CoV-2 variant BA.2.86 and XBB sub-lineages by a tetravalent COVID-19 vaccine booster.

Journal: Cell host & microbe

Published: September 15, 2023

Potent and broadly neutralizing antibodies against sarbecoviruses induced by sequential COVID-19 vaccination.

Potent and broadly neutralizing antibodies against sarbecoviruses induced by sequential COVID-19 vaccination.

Journal: Cell discovery

Published: August 28, 2023

In Vitro Antibody-Dependent Enhancement of SARS-CoV-2 Infection Could Be Abolished by Adding Human IgG.

In Vitro Antibody-Dependent Enhancement of SARS-CoV-2 Infection Could Be Abolished by Adding Human IgG.

Journal: Pathogens (Basel, Switzerland)

Published: July 18, 2023

Showing 1-12 of 13

Last Updated: 09/26/2026